SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-263886
Filing Date
2020-10-05
Accepted
2020-10-05 16:16:24
Documents
8
Period of Report
2020-11-17
Effectiveness Date
2020-10-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A d907623ddef14a.htm DEF 14A 355346
2 GRAPHIC g907623g11y77.jpg GRAPHIC 26592
3 GRAPHIC g907623g21j11.jpg GRAPHIC 24658
4 GRAPHIC g907623g23u32.jpg GRAPHIC 65162
5 GRAPHIC g907623g56z83.jpg GRAPHIC 16586
6 GRAPHIC g907623g57f70.jpg GRAPHIC 22487
7 GRAPHIC g907623g65d12.jpg GRAPHIC 46326
8 GRAPHIC g907623g84y44.jpg GRAPHIC 22433
  Complete submission text file 0001193125-20-263886.txt   666275
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38268 | Film No.: 201223758
SIC: 2836 Biological Products, (No Diagnostic Substances)